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Introduction
Brain metastases (BMs) are the most common tumors 
in the human central nervous system (CNS), with an 
occurrence ten times higher than primary brain tumors 
in adults. A radiologist usually diagnoses these tumors. 
Typically, magnetic resonance imaging (MRI) has been 
used to evaluate the status and amount of metastases, 
the design of surgical treatment or radiotherapy, and the 
response to treatment. Newer techniques of MRI have 
also been used to help diagnose single BM due to high-
grade gliomas or abscesses.1
BM is a recurrence of cancer associated with high 
mortality. Types of primary tumors are different in their 
tendency to produce BMs with kidney cancer, breast 
cancer, and lung cancer (squamous cell lung, SCC), which 
show most of such cases related to the CNS. The survival 
time prediction of BM patients is only a few months. 
Several scores presented to classify the risks of metastases 
such as recursion parameters, prognostic evaluation 
(GPA), and diagnostic grading prognostic evaluation 
(DS-GPA). These results are based on guidelines with 
diagnostic properties, containing performance status, age, 
primary tumor condition, previous extant metastases, 
and BM numbers. The average overall survival from BM 
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Abstract
Background: Brain metastases are the most common tumors in the human central nervous system 
(CNS), with an occurrence 10 times higher than primary brain tumors in adults. A radiologist usually 
diagnoses these tumors. Typically, magnetic resonance imaging (MRI) has been used to evaluate the 
status and number of metastases, the design of surgical treatment or radiotherapy, and the response 
to treatment. This study aimed to consider the origin of metastatic tumors of the brain using diffusion-
weighted imaging sequence.
Methods: In this study, 95 lesions observed in 51 patients with different types of brain metastasis 
who analyzed with standard brain MRI protocols such as T2-weighted fast spin-echo in sagittal, 
coronal and axial planes and T1-weighted spin-echo sequences before and after injection of contrast 
enhancement and diffusion-weighted imaging. The diffusion-weighted imaging included an echo-
planar spin-echo sequence with two b values (0,1000 s/mm) and calculated apparent diffusion 
coefficient (ADC) maps. We measured the ADC-value on normalized ADC maps and compared 
them with different methods. ANOVA was used to compare ADC among all groups as well as T-test 
for every two groups. 
Results: The results showed that patients with lung cancer (squamous cell carcinoma,  SCC)  had 
the lowest mean ADC (658.70*10-3 mm2/s) and breast cancer patients with the highest mean 
ADC(935.52*10-3 mm2/s). This study demonstrated that most Brain metastases had low and 
intermediate ADC values. The analysis showed no significant difference among all groups. However, 
ADC values in breast cancer and kidney and lung (adenocarcinoma) were statistically higher in 
comparison to other groups. There were no critical discrepancies between ADC values in brain 
metastases from Breast cancer and lung cancer (adenocarcinoma) and kidney.
Conclusion: It seems that evaluating the origin of the brain metastatic tumors by using diffusion 
imaging (DWI) parameters could be helpful to prevent invasive methods like biopsies in some 
situations. Although it needs more studies to achieve this purpose. 
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identification is only 3 months. The optimal group, up to 
a maximum of 25.3 months, is among the most popular 
groups, including long-term survivors. Imaging scalars 
have not considered for prognostic hazard classification 
with the exclusion of the numeral of BM. MRI using the 
T1 weighted, T2 and FLAIR weighted imaging for the 
routine brain protocol to the determination of tumors; 
and for better visualizing the area of tumor injecting 
the contrast media. Increasingly, advanced imaging 
techniques such as magnetic resonance spectroscopy, 
MRI perfusion, or diffusion imaging (DWI) are used to 
describe brain lesions in order to provide more clinical 
information.2 
Early diagnosis of BMs is an achievement of the 
precise and innovative methods of CNS imaging which, 
like the advancement of oncology treatments, leads to 
prolonged survival of the patient, as well as an increase 
in the incidence of metastases in the brain. Standard 
MRI sensitivity is high, but its characteristics are limited 
in the diagnosis of brain tumors and modifications in its 
treatment.3
In the routine MRI, signal strengths of the brain 
tumors may change due to their histopathology. They 
also show a different signal intensity in MRI, according 
to their components (i.e., solid tumors, degeneration, 
hemorrhage, and cysts). The signal intensities for these 
tumors have informed in the diffusion-weighted imaging. 
These tumors can precipitate an abscess or early infarction 
in diffuse images. To understand the intensity of the 
signal in diffusion images, understanding its mechanism 
is essential. DWI can show early changes and minor areas 
of the brain that are not visible on routine imaging. DWI 
includes both quantitative and qualitative information 
that can be very important for tumor detection.4
MRI of the brain is commonly used for the investigation 
of patients and follow them up, and DWI sequences are 
commonly used to distinguish tumors from abscesses. 
Recently, however, it has been used to help differentiate 
metastasis from the glioma, to design surgical treatment 
and even to predict the treatment process. In BM, it is 
noticeable that the apparent diffusion coefficient (ADC) 
increases with decreasing cellulite, and the tissue buildup 
within the tumor increases.5 
An embodiment of the motion of water molecules in 
the extracellular space is the principle of imaging based on 
diffusivity. The constrained movability of water molecules 
caused low exudation ability reduces the diffusion in 
extracellular space; this function of water molecules make 
a  hyperintense signal in the DWI and low ADC values. 
In return, the excessive emission rate due to increased 
mobility of water molecules produces a hypo or iso signal 
on DWI and high ADC values.
DWI indications examined to show a correlation with 
different histopathologic distinguishing; such as tumor 
category, tumor grade, tumor cell concentration, cellulite, 
or intracerebral hemorrhage, and prognosis of survival 
in several cases in the types of tumors inside and outside 
the cranium. However, the correlation of prediction with 
DWI and histomorphologic evidence in patients with BM 
have not been methodically deliberated yet.2
Metastatic tumors of the brain are usually diagnosed 
accidentally due to neurological symptoms in the patient 
or following a CT scan or MRI of the brain region. Less 
than 10% of the BMs diagnosed before primary cancer, 
and this is when the patient undergoes a CT scan or 
MRI for other medical reasons, and the tumor detected 
randomly. The patient may not have any neurological 
symptoms and a history of cancer at the time of referral. 
Doctors currently perform biopsies to insistent the origin 
of metastatic tumors or use MRI and CT scans for other 
parts of the body to identify the origin of the tumor. 
For patients with brain, metastases are surgery, and 
whole-brain radiotherapy (WBRT) is the most common 
medication. If corticosteroids prescribed along with 
some systemic treatments, it can also influence cranial 
metastases. Repeated WBRT is available for part of the 
brain, but the effectiveness of this method is relatively low. 
There is a need for new therapies, and among innovative 
clinical trials, radiotherapy and stereotactic biopsy have 
considered as innovative therapies.6
Stereotactic biopsy is a surgical procedure in which 
a thin needle is inserted into the brain by a surgeon to 
extract a small piece of tissue for examination under 
a microscope. Stereotactic biopsy using 3D imaging 
technology, as well as CT scan and MRI data, are utilized 
for testing a tumor or a part of the brain. Stereotactic 
biopsy is a minimally invasive method. The highest risk is 
the bleeding that can cause anything from mild headaches 
to stroke, coma, or even death. The risk of post-biopsy 
bleeding is about 5%, and the risk of death is about 1%. 
Other post-biopsy side effects include headache at the site 
of biopsy, infection, and seizure. Moreover, the dangers 
that can be caused by anesthesia are inevitable.7
The purpose of this study was to implement a new non-
invasive approach to recognize the origin of brain tumors 
by using MR imaging before surgery.
Materials and Methods
Patients
The study community included patients who had cancers 
and referred to the MRI department with a neurosurgeon’s 
definitive diagnosis for the treatment, recurrence, or 
recovery of the disease. Among 10 000 chronological 
patients who underwent MR imaging in Shohadaie 
Tajrish hospital among 2015 and 2017, 1285 people were 
imaged to find out BM. After the imaging, 125 patients 
were noticed, between who mistrustful to BM.
Therefore 60 of 125 patients had conventional MR 
imaging and DWI in their history of MRI. We excluded 
9 of 60 patients from our study because of different 
diagnoses such as hemorrhage, primary brain tumors like 
glioblastoma or astrocytoma, and any other lesions. 
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MRI Examination 
MRI performed with a 1.5T system (Avento; Siemens, 
Erlangen, German) with an 8-channel head coil. We 
obtained T1-weighted images with imaging parameters of 
675/15(TR/TE), a slice thickness of 5 mm, an interslice 
group of 1.5 mm, a field of view of 20 to 24, and a matrix 
of 320*256; T2-weighted spin-echo images with imaging 
parameters of 4000/85 (TR/TE) ), a slice thickness of 
5 mm, an interslice group of 1.5 mm, a field of view of 
20 to 24, and a matrix of 320*256; fat-suppressed short 
tau inversion recovery (FLAIR) imaging parameters of 
9000/125(TR/TE), a slice thickness of 5mm, an interslice 
group of 1.5 mm, a field of view of 20 to 24, and a matrix 
of 256*192; and DWI was performed in the transverse 
plane using a spin-echo, echo-planar imaging sequence 
with the following parameters of 6000/102 (TR/TE), a 
slice thickness of 5mm, an interslice group of 1.5 mm, a 
field of view of 20 to 24, and a matrix of 128*128, diffusion 
gradient encoding in 3 orthogonal directions; b = 1000s/
mm2. DWI scans performed before contrast-enhanced 
T1-weighted imaging. T1-weighted spin-echo images 
after intravenous administration of contrast medium with 
a dose of 0.1 mg/kg obtained.
The ADC values calculated as follows: ADC = -[In(S/
S0)]/b, where S is the SI of the region of interest (ROI) 
obtained 3 orthogonally oriented DWIs or diffusion trace 
images, S0 is the SI of ROI acquired through reference 
T2-weighted images and b is the gradient b factor with a 
value of 1000 s/mm2. The ADC maps were calculated on 
a pixel-by-pixel basis.1 
In the following step, measurement of the signal 
intensity of the lesion in DWI images was done in 
two ways: by the radiologist and by using software 
calculations, a quantitative measure of the intensity of the 
signal was done placing the ROI onto the lesion (center of 
each lesion). 
All patients also provided with a pathologist’s report, 
which determined the origin of metastatic brain tumors. It 
is necessary to know pathological information to compare 
and connect the ADC parameter and signal intensity with 
the origin of tumors.
Image Analysis
All MR images were read by a radiologist experienced 
in the brain MRI interpretation who did not have any 
previous knowledge regarding the histopathological type 
of the brain.
Conventional MR images assessed for the evaluating 
features of each BM. We selected the tumor with short-
axis larger than 1 mm.
The final number of BM that selected in the analysis 
was equal to 95. In the case of a patient with multiple BM, 
everyone evaluated separately. The assessment of ADC 
value includes drawing 3 ROIs with the same diameter 
for covering the pathologic area in all sections in which 




Figure 1. Placing ROIs on the ADC map. 45-year-old female breast 
cancer presents with nausea. (A) Postcontrast T1-weighted sequence 
demonstrate a lesion. (B) An ADC map generated from B=1000 
images. (C) Flair sequence to investigate the area of edema. (D) Three 
ROIs are drawn interior the tumor border.
the area of ROIs for accounting these different ADC 
values; 3 uniforms ROIs composed of more than 10 pixels 
were manually drawn to calculate the SI on T2-weighted 
images and the ADC values on the map. In this study, 
we excluded the edematous areas from analysis to avoid 
presenting a false high ADC. All the ADC values were 
averaged from three-time measurement and expressed as 
the mean ± standard deviation. Three ADC values (min 
ADC, max ADC, mean ADC) calculated for all selected 
brain tumors. 
Apparent Diffusion Coefficient
The axial slice with the largest size of the tumor has chosen, 
and three elliptical ROIs of 10 mm2 were drawn within 
the borders of the tumor on ADC maps, avoiding areas of 
cyst, necrosis or hemorrhage. The Radiant software then 
delivers the maximum and minimum ranges for the given 
ROIs. Placing the ROIs were displayed in Figure 2.
In this study, ANOVA and t test were used to calculate 
the data and connect the factors. For ease, analyses of 
the data related to the signal intensity and ADC done 
separately. Finally, ADC values correlated with the 
pathology reports of the brain dissection samples.
Results
In this study, 95 lesions observed in 51 patients. The mean 
age of patients was 51.6±11.9 years. The youngest was 24, 
and the oldest age was 78. The total number of patients 
participating in this study was 28 women (54.9%) and 23 
men (45.1%).
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The maximum number of BMs resulted from breast 
cancer, followed by lung (adenocarcinoma) and 
gastrointestinal cancer.
The mean ADC values were 935.52*10-3 mm2/s for breast 
cancer, 903.06*10-3 mm2/s for lung (adenocarcinoma), 
847.89*10-3 mm2/s for kidney, 755.27*10-3 mm2/s for 
ovarian, 723.51*10-3 mm2/s for GI, 720.02*10-3 mm2/s for 
melanoma, 682.17*10-3 mm2/s for cervix and 658.70*10-3 
mm2/s for lung (Table 1). 
The results showed that patients with lung cancer had 
the lowest mean ADC (658.70*10-3 mm2/s) and breast 
cancer patients with the highest mean ADC (935.52*10-
3 mm2/s). This study demonstrated that most BMs had 
low and intermediate ADC values. The analysis showed 
no significant difference among all groups. However, 
ADC values in Breast cancer and kidney and lung 
(adenocarcinoma) were statistically higher in comparison 
to other groups. There were no critical discrepancies 
between ADC values in BMs from breast cancer and lung 
cancer (adenocarcinoma) and kidney.
Discussion
DWI has been used to depict water movability in white 
matter and gray matter of the brain.8 The most typical 
indication of DWI is differentiating cerebral infarction, 
multiple sclerosis, gliomas, and brain abscesses, arachnoid, 
and epidermoid cysts and other diseases.9,10 
Nowadays, medical science in the field of surgery 
A B C
Figure 2. Imaging Findings of Brain Metastasis in Lung Adenocarcinoma. 
(A) T1-weighted image after intravenous administration of contrast 
medium showing lesion with inhomogeneous enhancement. (B) The 
lesion had edema in flair sequence. (C) ADC map. The calculated 
ADC values range shown and how the ROIs placed. .
Table 1. Descriptive Indicators for the Mean ADC of Lesion Area by the Type of Cancer
Type of Cancer Average Middle Standard Deviation Min Max
Breast 935.52 983.13 207.53 501.00 1294.75
Cervix 682.17 639.00 115.03 525.0 976.14
GI 723.81 689.71 140.73 475.40 993.00
Kidney 926.26 937.71 245.00 670.00 1236.00
Lung (adenocarcinoma) 903.06 832.83 289.43 432.43 1464.71
Melanoma 720.02 682.00 105.88 520.00 939.00
Ovarian 755.2 773.63 59.73 617.00 844.67
Lung (SCC) 658.70 628.14 166.78 443.38 1093.00
is making strides towards finding ways to do surgery 
without the need for an incision in the patient’s body, and 
in order to reduce the number of complications of the 
operation. In this regard, the relevant tools and software 
can be handy.
Therefore, research in this area is at the center of the 
attention of doctors, especially surgeons. Accordingly, 
in this study, with the help of software, introspection of 
brain intra-axial tumors was investigated, and significant 
results obtained. The results of the study showed that 
using MRI and some sequences optimized and sensitized 
to registering a diffusion and with the assistance of 
advanced software analysis, useful information about 
the origin of a metastatic tumor can be found. This is 
a path to finding the answers to some questions about 
the origins of a metastatic tumor for which the current 
procedure includes biopsies in order to accede an answer. 
It should note that similar qualitative and visual studies 
in other countries have not yet achieved reliable results.
Metastatic tumors of the brain are usually diagnosed 
accidentally due to neurological symptoms in the 
patient or following a request for CT scan or MRI from 
the brain region. Less than 10% of the brain metastases 
detected before the early cancers, and this is when 
the brain subjected to a CT scan or MRI test for other 
medical reasons, and the tumor diagnosed accidentally, 
and the patient may be at the time of referral, there is no 
neurological symptoms and no history of cancer.4
Considering the fact that metastatic tumors have 
various origins, finding the area of the body causing 
metastasis in the brain region is one of the critical points 
for the diagnosis and treatment of patients, as well as the 
choice of therapies such as radiotherapy, chemotherapy, 
and surgery related to the technical information of value 
that imaging has achieved. Due to the complexity of 
this technique of imaging and the absence of effective 
education of expert physicians and imaging centers, the 
comprehensive applications of this method, like study of 
the origin of metastatic tumors, as well as the evaluation 
of the response to treatment before and after therapeutic 
procedures, require further studies in this field.6,9,10
In this research, bringing the facility of the RADIANT 
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software, and using a sensitive sequence for displaying 
changes in water content of structures, factors were 
considered, ADCs. The analysis of the DWI sequence 
achieved. There is no significant distinction between the 
ADCs of the surrounding area of the tumor in the different 
groups, while there is a critical difference between the 
ADCs of the tumor center and the area around the tumor, 
as well as between ADC values of the tumor center in 
different groups. For example, Kono et al,10 in 2001, 
carried out-DWI in patients with brain tumors, found 
that ADC could be useful in detecting the malignancy 
of astrocytoma and glioblastoma They also exhibit low-
grade astrocytoma, ADC-value more than the rest of the 
tumors, and ADC is associated with the origin of tumors 
in both astrocytoma and meningioma.
Studies have indicated that a lower-grade tumor has an 
ADC-value higher than that of high-grade tumors, and 
this part of the findings from this study is similar to the 
results from our fact-finding, so that metastatic tumors 
the origin of metastatic lung (SCC) tumors with lower 
ADC produces more severe damage to the brain and 
lung cancer (SCC) is the most occasion of metastasis 
in the brain from all dominant tumors that occurrence 
metastases in brain. The lung cancer has a short cycle 
of time from the moment that primary cancers were 
determined, and also has the short cycle of time to death 
(3 months).10 
Also, Berghoff and colleagues concluded in 2013 that 
they performed diagnostic tests in patients with metastatic 
tumors and their relation to survival time. The metastatic 
tumors have a signal intensity greater than or equal to the 
brain tissue, and in tumors with higher signal strengths 
in DW images, they have shorter survival time than other 
tumors. In this study, they did not mention the numerical 
values of the ADC parameter, nor did they mention the 
paternity of the tumor and the type of tumor,5 but in 
our results we found the relationship between the tumor 
cluster and the type of tumor in which the statistical results 
obtained show this in data analysis of ADC parameter 
using RADIANT software and paired t-test, the significant 
correlation found between numerical values of the ADC 
of the metastatic tumor site with the origin of kidney, 
breast, and lung (adenocarcinoma) with other groups of 
BM. As we can see, there is a critical discrepancy between 
the ADC values of the tumor center with the origin of 
kidney, breast, and lung (adenocarcinoma) with different 
groups, in summary, it can be stated that the tumor is 
more malignant, the lower the ADC number. 
This explanation suggests the ADC map independently 
afford extra, bizarre, scientifically useful information 
in comparison with the post-contrast T1-weighted 
sequences.11
On the other hand, in the analysis of signal strength data 
using RADIANT software and paired t test and ANOVA, 
a significant correlation found between the intensity of 
the signal of the metastatic tumor center with different 
origins. As can be seen, there is no critical discrepancies 
in the signal intensity around the tumor in disparate 
groups, and there is a critical discrepancy among the two 
groups. However, there is a significant difference between 
the intensity of the signal of the tumor center in different 
groups — for example, a study by Hayashida et al in 
2006 concluded that the intensity of the signal obtained 
in DW images reflects the histological characteristics 
of metastasis. In DW images, we can increase the 
irritability of the sequence to the lesions by varying the 
b-values and obtain different signal strength,3 so in our 
studies, RADIANT software has been used to measure 
the intensity of the signal. In this paper, the intensity of 
the signal in the DWI sequence is compared with that 
of the eye, while the use of parameters can change the 
intensity of the signal, and on the other hand, in the DWI 
sequence, the intensity of the signal is influenced by the 
phenomenon of random motion of water molecules, but 
in the intensity sequence T2 the signal is also contrived 
by the diffusion appearance and the comforting moment 
of T2, so it is slightly more accurate. Studies in this regard 
advocate that brain metastatic tumors with lung origin 
cause more damage to the blood-brain barrier and, on the 
other hand, create more cellular discharges which would 
lower the ADC number in this group of patients. Also, 
this category of Tumors causes massive and unconscious 
effects in the tumor site, which is one of the reasons for 
lower ADCs.2
Suggestions for Future Studies
This study is capable of performing in areas other than 
the brain, such as pituitary lesions, liver, limb mass, and 
similar software programs used in this study to identify 
the origin of the tumor. Also, more advanced software 
can be used to obtain more accurate results. A further 
limitation was the low number of patients included in 
the sample. Further studies can report better and more 
accurate results regarding DW-MRI by choosing more 
samples.
Conclusion
The histology of brain metastases may forecast the signal 
intensity on DWI. Metastatic brain tumors with the vary 
of histologic category indicated different signal intensity 
on DWI. The results of this paper state that most brain 
metastases had low and intermediate ADC values. Our 
explanation found an extensive irregularity of BM-ADC 
values. It seems that evaluating the origin of the brain 
metastatic tumors by using DWI parameters is a useful 
technique to eliminate invasive methods like biopsies.
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